Article Information
History
- April 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Thomas Perkmann1,
- Thomas Koller1,
- Nicole Perkmann-Nagele1,
- Miriam Klausberger2,
- Mark Duerkop3,
- Barbara Holzer4,
- Boris Hartmann4,
- Patrick Mucher1,
- Astrid Radakovics1,
- Maria Ozsvar-Kozma1,
- Oswald F Wagner1,
- Christoph J Binder1 and
- Helmuth Haslacher1,*
- 1Department of Laboratory Medicine, Medical University of Vienna, Austria
- 2Institute of Molecular Biotechnology, Department of Biotechnology, University of Natural, Resources and Life Sciences (BOKU) Vienna, Austria
- 3Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU) Vienna, Austria
- 4Department for Animal Health, Austrian Agency for Health and Food Safety (AGES), Moedling, Austria
- ↵*Corresponding author: Helmuth Haslacher, LECT MD PHD MSC BSC BA, Medical University of Vienna, Department of Laboratory Medicine, Waehringer Guertel 18-20, 1090 Vienna, Austria, helmuth.haslacher{at}meduniwien.ac.at, Phone: +43 1 40400 53190, FAX: +43 1 40495 15547
Posted April 11, 2021.
Spike protein antibodies mediate the apparent correlation between SARS-CoV-2 nucleocapsid antibodies and neutralization test results
